Altamira Therapeutics Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Altamira Therapeutics are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Altamira Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Altamira Therapeutics is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 15.4 K |
Altamira |
Altamira Therapeutics Relative Risk vs. Return Landscape
If you would invest (100.00) in Altamira Therapeutics on November 27, 2024 and sell it today you would earn a total of 100.00 from holding Altamira Therapeutics or generate -100.0% return on investment over 90 days. Altamira Therapeutics is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Altamira, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Altamira Therapeutics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Altamira Therapeutics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Altamira Therapeutics, and traders can use it to determine the average amount a Altamira Therapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CYTO |
Based on monthly moving average Altamira Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Altamira Therapeutics by adding Altamira Therapeutics to a well-diversified portfolio.
Altamira Therapeutics Fundamentals Growth
Altamira Stock prices reflect investors' perceptions of the future prospects and financial health of Altamira Therapeutics, and Altamira Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Altamira Stock performance.
| Return On Equity | -3.69 | |||
| Return On Asset | -0.57 | |||
| Current Valuation | 860.75 K | |||
| Shares Outstanding | 3.78 M | |||
| Price To Book | 0.08 X | |||
| Price To Sales | 0.64 X | |||
| EBITDA | (1.35 M) | |||
| Cash And Equivalents | 984.19 K | |||
| Cash Per Share | 1.29 X | |||
| Total Debt | 99.66 K | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | 2.37 X | |||
| Cash Flow From Operations | (11.51 M) | |||
| Earnings Per Share | 1.82 X | |||
| Total Asset | 7.69 M | |||
| Retained Earnings | (18.05 M) | |||
Things to note about Altamira Therapeutics performance evaluation
Checking the ongoing alerts about Altamira Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Altamira Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Altamira Therapeutics is not yet fully synchronised with the market data | |
| Altamira Therapeutics has some characteristics of a very speculative penny stock | |
| Altamira Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Altamira Therapeutics currently holds 99.66 K in liabilities with Debt to Equity (D/E) ratio of 0.05, which may suggest the company is not taking enough advantage from borrowing. Altamira Therapeutics has a current ratio of 0.75, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Altamira Therapeutics' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (3.87 M) with loss before overhead, payroll, taxes, and interest of (2.18 M). | |
| Altamira Therapeutics currently holds about 984.19 K in cash with (11.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.29. |
- Analyzing Altamira Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Altamira Therapeutics' stock is overvalued or undervalued compared to its peers.
- Examining Altamira Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Altamira Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Altamira Therapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Altamira Therapeutics' stock. These opinions can provide insight into Altamira Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Altamira Stock
If you are still planning to invest in Altamira Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Altamira Therapeutics' history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |